Camberwin Pharmaceuticals Private Limited
About Camberwin Pharmaceuticals Private Limited
Data last updated:
Camberwin Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2015PTC047218. Its GSTIN is 08AAFCC9732R1ZV (Rajasthan).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Mukesh Kumar Yadav and Manish Kumar Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P. No. N – 13 Purana (14) F – 1 Hanuman Vatilka, Jaipur, Rajasthan, India – 302006.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.16 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹1.36 Lakh (net margin 1.2%) and EBITDA of ₹1.97 Lakh (EBITDA margin 1.7%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressP. No. N – 13 Purana (14) F – 1 Hanuman Vatilka, Jaipur, Rajasthan, India – 302006
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Camberwin Pharmaceuticals Private Limited
The main business activity of Camberwin Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Camberwin Pharmaceuticals Private Limited FY 2025 filings available
Camberwin Pharmaceuticals Private Limited reported revenue of ₹1.16 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Camberwin Pharmaceuticals Private Limited
Revenue rose 12% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Camberwin Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.97 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.36 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Camberwin Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Camberwin Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Camberwin Pharmaceuticals Private Limited
Camberwin Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oncure Pharma Private Limited | ₹1.16 Cr (FY 2017) | •••• | •••• | -22.0% | •••• | Thane, Maharashtra, India |
| Ferron Lifecare Private Limited | ₹1.16 Cr (FY 2023) | •••• | •••• | 4.0% | •••• | Ambernath, Maharashtra, India |
| Jamuway Pharmaceuticals Private Limited | ₹1.16 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Surat, Gujarat, India |
| Rinovex Pharma Private Limited | ₹1.16 Cr (FY 2025) | •••• | •••• | 1903.0% | •••• | Paonta, Himachal Pradesh, India |
| Prayash Health Care Private Limited | ₹1.16 Cr (FY 2025) | •••• | •••• | -43.0% | •••• | Secunderabad, Telangana, India |
| Camberwin Pharmaceuticals Private Limited this company | ₹1.16 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Jaipur, Rajasthan, India |
| Racer Pharma Private Limited | ₹1.16 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Bahraich, Uttar Pradesh, India |
| Soulsome Pharmaceuticals Private Limited | ₹1.16 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Kolkata, West Bengal, India |
| Karmic Meditraders Private Limited | ₹1.15 Cr (FY 2024) | •••• | •••• | -55.0% | •••• | Delhi, India |
| Grace N Cure Medipharma Private Limited | ₹1.15 Cr (FY 2025) | •••• | •••• | 417.0% | •••• | Varanasi, Uttar Pradesh, India |
| Vega Laboratories Private Limited | ₹1.15 Cr (FY 2023) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Camberwin Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Camberwin Pharmaceuticals Private Limited
Camberwin Pharmaceuticals Private Limited is audited by C. L. YADAV & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| C. L. YADAV & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Camberwin Pharmaceuticals Private Limited
Camberwin Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manju Yadav | Additional Director | 16 Mar 2018 | 8 Years 6 Months | Current |
| Kiran Yadav Also directs: Araawaly Organics Farmer Producer Company Limited | Additional Director | 16 Mar 2018 | 8 Years 6 Months | Current |
| Mukesh Kumar Yadav | Director | 17 Mar 2015 | 11 Years 6 Months | Current |
| Manish Kumar Yadav | Director | 17 Mar 2015 | 11 Years 6 Months | Current |
Ownership and Shareholding of Camberwin Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Camberwin Pharmaceuticals Private Limited
Camberwin Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Camberwin Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Camberwin Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Camberwin Pharmaceuticals Private Limited
Camberwin Pharmaceuticals Private Limited has 4 board changes on record since 2015: 4 appointments. The latest: Kiran Yadav was appointed as Additional Director on 16 Mar 2018.
Credit Ratings, Litigation & Regulatory Alerts for Camberwin Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Camberwin Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Camberwin Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Camberwin Pharmaceuticals Private Limited
Camberwin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAFCC9732R1ZV | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Camberwin Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Camberwin Pharmaceuticals Private Limited
Camberwin Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 March 2015 (11+ years old) and is registered under CIN U24232RJ2015PTC047218.
Camberwin Pharmaceuticals reported revenue of ₹1.16 Cr for FY 2025 (up 12% YoY).
Camberwin Pharmaceuticals has 4 current directors:
- Manju Yadav - Additional Director
- Kiran Yadav - Additional Director
- Mukesh Kumar Yadav - Director
- Manish Kumar Yadav - Director
Camberwin Pharmaceuticals reported a net profit of ₹1.36 Lakh (net margin 1.2%) and EBITDA of ₹1.97 Lakh (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Camberwin Pharmaceuticals is 10% over three years and -4% over five years. In the latest year (FY 2025) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Camberwin Pharmaceuticals is 08AAFCC9732R1ZV, registered in Rajasthan.
The CIN (Corporate Identification Number) of Camberwin Pharmaceuticals is U24232RJ2015PTC047218. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Camberwin Pharmaceuticals was incorporated on 17 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Camberwin Pharmaceuticals by revenue are Oncure Pharma Private Limited, Ferron Lifecare Private Limited, Jamuway Pharmaceuticals Private Limited, Rinovex Pharma Private Limited, Prayash Health Care Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Kiran Yadav was appointed as Additional Director on 16 Mar 2018. Manju Yadav was appointed as Additional Director on 16 Mar 2018. Manish Kumar Yadav was appointed as Director on 17 Mar 2015. Camberwin Pharmaceuticals has 4 board changes on record in total.
The registered office of Camberwin Pharmaceuticals is at P. No. N – 13 Purana 14 F – 1 Hanuman Vatilka, Jaipur, Rajasthan, India – 302006.